Section A Project A02
Inflammation-induced intestinal epithelial regulated necrosis as a novel modulator of bone resorption

Project leaders

Thanks to complementary expertises, project A02 will focus on inflammation-driven bacterial dysbiosis in the gut and how associated alterations in the metabolome affect joint and bone homeostasis. The project is built on the strong expertise of both PIs on mucosal and osteo-immunology and will delineate the impact of microbe-epithelial communication in the gut on the gut-bone axis. Preliminary data implicate that microbiota-dependent and -independent mechanisms driven by caspase-8 deficiency in the intestinal epithelium influence serotonin production in the gut, associated with a pathophysiological bone loss triggered by an alteration in osteoblast/osteoclast homeostasis. The key hypothesis of the project is that regulated necrosis of intestinal epithelial cells and associated alterations in intestinal metabolites (host and microbiota) promote inflammatory bone loss by altering tryptophan metabolism. They will follow their previous and preliminary data and mechanistically analyze how these novel players affect bone homeostasis and osteogenesis by taking advantage of a well-established mouse model for IBD (Casp8ΔIEC mice) (Günther, et al., 2015; Günther, et al., 2011) as well as human biosamples and ex vivo organ cultures.

The Science

This research project explores the impact of chronic intestinal inflammation, such as in inflammatory bowel disease (IBD), on bone health. It aims to understand how gut inflammation leads to bone diseases like osteoporosis by examining the role of intestinal cell death and microbial by-products. The project will investigate how changes in gut-derived serotonin levels and other factors contribute to bone loss. Insights gained from studying both mouse models and patient samples will help develop new strategies to prevent and treat inflammation-induced bone loss. This work is crucial for improving the quality of life for individuals with chronic intestinal conditions.

Gastroenterology
Prof. Dr. Aline Bozec
+49 151 15 21 55 74
bozec.aline@outlook.com

Team